Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
40.53
-0.84 (-2.03%)
At close: Mar 20, 2026, 4:00 PM EDT
41.62
+1.09 (2.69%)
After-hours: Mar 20, 2026, 7:54 PM EDT

Vera Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
354.7392.6545.6843.4679.67
Short-Term Investments
359.86548.21115.0471.19-
Cash & Short-Term Investments
714.59640.85160.72114.6579.67
Cash Growth
11.51%298.75%40.18%43.90%48.50%
Other Current Assets
14.2910.3711.3111.052.86
Total Current Assets
728.88651.22172.02125.782.54
Net Property, Plant & Equipment
3.34.333.045.22-
Long-Term Investments
---0.060.87
Other Long-Term Assets
2.550.130.480.460.34
Total Assets
734.73655.68175.55131.4483.75
Accounts Payable
21.97.6711.1211.991.39
Accrued Expenses
31.0116.228.7510.965.93
Current Portion of Leases
0.551.482.442.65-
Other Current Liabilities
----0.38
Total Current Liabilities
53.4625.3722.325.67.69
Long-Term Debt
74.8450.6949.8824.814.92
Long-Term Leases
1.922.471.43.83-
Other Long-Term Liabilities
--0.290.291.54
Total Long-Term Liabilities
76.7653.1651.5628.936.47
Total Liabilities
130.2178.5373.8654.5314.16
Common Stock
0.070.060.040.030.02
Additional Paid-in Capital
1,3651,038410.49290.22193.63
Accumulated Other Comprehensive Income
0.790.390.25-0.22-
Retained Earnings
-760.87-461.25-309.1-213.11-124.06
Total Common Shareholders' Equity
604.52577.16101.6976.9169.59
Shareholders' Equity
604.52577.16101.6976.9169.59
Total Liabilities & Equity
734.73655.68175.55131.4483.75
Total Debt
77.3154.6453.7131.294.92
Net Cash (Debt)
637.28586.21107.0183.3774.75
Net Cash Growth
8.71%447.82%28.36%11.53%39.32%
Net Cash Per Share
9.9210.602.513.145.56
Book Value
604.52577.16101.6976.9169.59
Book Value Per Share
9.4110.432.382.895.18
Tangible Book Value
604.52577.16101.6976.9169.59
Tangible Book Value Per Share
9.4110.432.382.895.18
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q